Circ-MFN2 has been reported to be highly expressed in osteosarcoma, hepatocellular carcinoma, and gastric cancer, and can promote the development of cancer (Deng et al., 2018; Liu et al., 2018; Li and Liu, 2020). Here, MFN2 is linked to cancer.